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ABSTRACT 
Bullous pemphigoid is characterized by the presence of both circulating and tisl'lue-fixed 
antibasement-membrane zone (BMZ) antibody. The present study determined the organ 
location and specificity of antibody fixed in vi\•o from a patient who died with active 
pemphigoid. Direct immunofluorescence (IF) of several organs revealed BMZ antibody only 
in the skin, esophagus, and vagina. BMZ antibody, however, was eluted with citric acid 
buffer (pH 2.2) from skin. esophagus, vagina. and trachea. The eluted antibody was similar 
to the circulating pemphigoid antibody in terms of IgG subclass. tubular pattern, and 
inability to fix complement. However, the two antibodies do not seem to share the same 
antigenic site or at least do not share equal affinity for the antigenic sites. Complement 
studies revealed activation of both the classic and the alternate pathways within the tissue 
and reduction of all complement components within the blister fluid . 
Bullous pemphigoid is a disease of the skin 
characterized clinically by large tense blisters. The 
disease seems to be limited to the skin. Previous 
reports have not indicated extracutaneous organ 
dysfunction or specific pathologic findings. We 
have had the opportunity to study a patient with 
bullous pemphigoid, and we were able to demon-
strate the presence of antibody (Ab) in several 
tissues of the body. Furthermore, we were able to 
show that this antibody could be dissociated from 
the tissue by acid elution, and that it was, as 
expected. a basement-membrane antibody. ln 
additional studies, we compared this antibody 
eluted from the tissue with the circulating serum 
Ab. As an extension of our studies of tissue-bound 
antibody, we investigated the complement system 
both in the tissue and in the blister n uid. 
MATERIALS AND METffOOS 
Case Hi.~tor'l' 
An 83-year-old woman had a 10-year history of a 
blistering disease that was well controlled by methyl-
prednisolone. Her only other medical problem was a 
chronic urinary tract infection. She had neither clinical 
nor laboratory evidence of connective tissue disorder. 
Mainly because congestive heart failure had developed, 
steroid withdrawal was attempted 4 months prinr to her 
death in April 1912. 
The blistering eruption recurred when steroid therapy 
was stopped. At this time the serum basement-membrane 
antibody titer was I :512. Prednisone therapy was re· 
s umed, and a moderate dose (40 50 mg daily) was 
sufficient to control the eruption until the l>atient died 
from congesti\·e heart failure in April 1972. 
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Tissues and Sera 
Serum and blister nuid were obtained .J mnnths prior 
to deat h and additional serum was obtained at autopsy. 
Also at autopsy, a strip of normal skin (length, 35 em; 
width. 6 em\ was obtained together with tissue specimens 
of kidney, esophagus, trachea, spleen. li,·er, bladder, 
lung, vagina. and intestine. 
l mmunofluore.,cente 
D1rect immunofluorescenre. Direct tmmunonuores -
cence was performed on all tissues ac('ordit\g to the 
methods pre,•iously described [I j. Monospecific goat 
antihuman flu(lrescein conjugal eo t Hy land Laboratories. 
Los Angeles ) were used; the characteristics of the conju-
gate~ also have been previously described 12]. 
Dr. Thomas Provost did ~pecial studiel> on the comple-
ment bound to the skin , using lluorescein-tagged mono-
spel·itic antisera to the following complement compo-
nents: Clq. C3. C4, C5, Ca proactivator. and properdin. 
Characteristics oft hese antisera have been described [3 ]. 
lndtrect immuno{luorescence.Initial indirect immuno-
fluorescence »tudil'~. in which ~erum or eluates were 
examined fCir the presence of antibodies. were performed 
on various ti~sues. Those tested tncluded tissues with an 
epithelial type of basement membrane, such as monkey 
and human esophagus. and human skin and tissue with 
an endothelial type of basement membrane, such as are 
found in kidney and lung. In addition, testing of homolo-
gous and heterologous tissue. sera, and eluates was done 
on sections of the patient's skin and esophagub (after 
removal of antibodies fixed in vivo) by incubation over-
night with 0.02 M ci trate buffer (pH 3.2) in Coplin jars at 
4" C fc>r 12 hr. Jndirect -immunolluorescent staining, with 
the u~e of a cnnju11ated antisera tu I11G. lgA. lj!M. and 
{J, ,/{1 11 (the sllme a~ used for direct immunofluores-
cence), was carried out in the standard manner [4] . 
Complement fixatwn by immunofluore.-c·ence. The 
complement immunonuore~l·ent techn1que was that de-
scribed hy ,Jordon. Sam~. and Beutner ]5] 
Hemolytic complement. complemenJ components, and 
CJ proactiuator in .~erum and bl1.~IPr fluid. Total heron-
lyt ic complement, Ca proactivator (C3PAl. and the 
ind1vidual functional complement componen ts (Cl 
throul(h C9l were measured in both serum and blil:.ter 
fluid by means of a technique prevwusly described ]6, 7]. 
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Eluate Stud1es 
The acid elution procedure was that described previ -
ously 18) . 
Tissul' preparation . Two types of dissection were done 
according to the nature of the organ studied. With 
viscera. such as the cortex of the kidney or the spleen or 
liver. the tissue was minced into small pieces and 
suspl'nded in phosphate-buffered sahne. When a hollow 
organ or an epithelium was studied, the mucosa was 
removed from the underlymg layer by careful dissection, 
cut mto small piecl's, and suspended m phosphate buff-
ered sahne. The skin was w atrophic from the effects of 
old age and con1costeroid therapy that it could be 
dlhheCted !rom the ~ubcutaneous ussuc~; cas1ly and pru 
cessed in the same manner as other epithelial Otl(ans. 
The small pieces ofiiSl.ue were homogemzed in a blender 
(VirTis) for 3 10 min at medium -high speed. This 
mixture was then cent rifuged at 2,000 , 11 for 30 min in a 
refngerated centrifuge CSorvall superspeed RC' -2). The 
sediment was resuspended in 400 ml of phosphate-buff. 
ered saline (pH 7.2) and was washed until the superna-
tant was c lear (8- 10 times) . Aliquots of every wabhing 
were tested for the presence of antinuclear antibody and 
basement-membrane antibodv by indire('l immunonuo-
rescence . 
Ac1d elut1on. The matenal obtamed was then treated 
with 10 volumes of 0.02 M citrate buffer (pH 2.2) and 
stirred O\•ernight at :17° C. The suspension was cen-
trifuged at 4.000 x R for :10 min, and the supernatant was 
neutralized with 0. 1 N NaOH and dialyzed se\•eral da\'b 
against multiple changes of phosphate-buffered saline at 
pH i .2. This eluate was concentrated 100-fold by p<tsl · 
live-pressure filtration through an Amicon Dianow mem· 
brane XM-100 to a final volume of0.5 I mi. 
Anubody Chorocterizouun 
Column chromaltJI(raph~ Chmmatographic !.epara-
tion of the serum (4 months pnor to death) wru; per-
formed tn order to define and di~U<' Iate \ anous base-
ment -membrane antibodies . Diethylaminoethyl cellulosl' 
(Whatman DE-52) chromatowaphy wa~ carried out a" 
described elsewhere 19]. The presence of basement-mem -
brane antibody wa!. examined in each peak with monke) 
esnphagus and nuorescein -conjugated ant ihurnan lgG 
(Fig. I) Complement fixing ability wa~ determined on 
each peak. 
In addition, lgG subclassing was performed us1ng 
conJUgate!\ prepared by Dr. P. H. 'chur. The charactens-
tics ol these antibodi!'s have heen dcscnhed prevu1usly 
19] . The basement-membrane zone !BMZJ anllh1ldy was 
found in fract1ons 2. 3, and 4 of tbe serum I months pnnr 
to death and in fraction 2 of tbe terminal "erum. It did 
not fix complement in any fra<'lion and d1d not contain 
lgG I <lr lgG:l. We were unable to determme the presem·e 
of lgG2 or lgG4 because our supply of these conjugates 
was exhausted. 
Preparation of ontlha.;ement-membrom.> ant1bCJdu•~ la-
beled u ith fluore.~cem l.;othwcyonate CFITC). Crystalline 
des1ccated nuorescein 1sothiocvanate ( BBL di\ision of 
BioQuest) was stored in the dark at 1° C until used. 
Conjugation was carr1ed out by the method ol Wood, 
Thompson. and Goldsrein f !OJ. Labeled fractions were 
used at a dilution of 1: 40. 
Th1s labeled ha8ement -membrane anubody was usPd 
m blocking experiment~ to determine \lohether the anti -
body eluted !rom the skin or the traC'hea was the ~a me as 
the one in the !.erum fractions. Secuons of monke:> 
esophagu~ were O\erlllld either wuh ..aline or w1th eluate. 
blister nuid, or serum DEAE fractions. After :lO min they 
were stained with the tluorescein-labeled serum fraction. 
To take into cons1deration the relative concentration of 
antibodies withm \•arious sera and eluates, a system of 
units was used One unit corresponded to the highest 
dilution Mill givmg basement-membrane staining. 
RESULTS 
Tissue Studies 
Direct immunofluorescence was performed on 
each tissue to determine the location of in vivo-
bound immunoglobulins and complement (Table 
I) . 
Jmrnuno fluo rescence studies of the tissues re-
vealed the presence of, first, linear IgG deposits on 
the basement-membrane a rea of the esophagus, 
skin (Fig. 2 A), and vagina, and, second, granular 
deposits of lgM on the glomerular basement mem-
brane. lgA deposits were found along the basement 
membrane of the skin 4 months prior to death. 
Except for one skin specimen (taken ov. !5, 
1971), no complement was fixed to epithelial 
basement membrane. At the time of death, the 
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patient's death Basement membrane antibody was 
found in fraction~ 2. 3, and 4 and did not fix complement. 
TABLE I 
Direct IF studies of tissue.' in bullou., pemphiROid 
Antihod1<., 
Ti>•ue Anli Anti Anll Anu· 
I ~G I~M l~A ('~ 
Skin (11/ 15/71) BM 2 ' I + l t I 2t 
Skin (4/ 12/72! BM Neg• Neg t\eg Neg 
lit Neg 1'\eg Neg 
K1dne) Neg 2 t '\eg :--leg 
Esophagus 2t t\eg t\eg :--leg 
Vagma I I Neg 'eg Neg 
Trachea, lung, liver, Ne~ Neg Neg Neg 
spleen, gut. bladder, 
ureter 
Using monu&pecific goat antihuman fluorescein conju-
gate: "1:25: t l : 125 
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Frc. 2: lmmunofluore;,cence studies ~howinl( depo,;its 
of lgG along basement membrane. A: Linear deposits of 
lgG along RMZ l'eparating epidermrs from dermis on skrn 
biopsy specimen taken 4 months prirJr to patient's death. 
(Fluorescein-conjugated antihuman lgG, l : l:l5 dilution; 
reduced from • :liiOJ H: At ume nl death, skin hrnpsy 
specimen is negat I\ e lor basement-membrane ant ihod~ . 
!Fiuorescem-conjugated antihuman !gG, I: 12!"1 dilution , 
reduced from " :QO) C: Harne skrn hrops\ specunen a~ in 
B but a conJugate five times more concenlr!Hed tl :25 
dilution) was used: a line linear dept>sll nl lgG alnn):( 
BMZ is now evtdent. tFiuorescem-tnnJugated anti -
human lgG; reduced \rom . ~\)(}) 
skin biopsy did not reveal binding of antibody at 
the skin BMZ when the routine antihuman IgG 
fluorescein conjugate was used. However, when the 
conjugate was concentrated five times, the base-
ment-membrane staining was evident (Fig. 2 B 
and C); and this observation is of clinical impor-
tance when a search is made for small amounts of 
in vivo-bound antibody. 
Serum and Bli.~ter Fluid Studies 
Indirect immunonuorescence was performed on 
the serum and blister fluid obtained 4 months prior 
to death (Table II) ; both gave the same titer. 
Neither serum nor blister fluid antibody fixed 
complement. Both serum and blister fluid base-
ment -membrane antibodies were of the IgG type. 
No ci rculating pemphigoid antibody belonged to 
the lgM or lgA class. 
Eluate Studies 
Eluates of the skin, esophagus, vagma. and t ra -
chea (Fig. :J) showed evidence of a basement-mem-
brane antibody when reacted with monkey esopha-
gus and human skin and esophagus and the pa-
tient's skin and esophagus after acid elution, hut 
no evidence of a basement-membrane antibody for 
either glomerular or lung tissue. No antinuclear 
antibody was eluted from any tissue. No antibody 
was eluted from kidney. lung, liver, intestine, 
spleen, or bladder. 
Characterization of Basement-Membrane Anti-
body in Eluates 
Immunoglobulin type. The eluted basement-
membrane antibody was always an IgG . 
Pattern. The pattern of staining of the basement 
membrane given by the eluted antibody was tubu-
lar and indistinguishable from the pattern given by 
the serum antibody. 
Titer. The titer of basement-membrane anti-
body in the skin and trachea eluate was 1:32 and 
in the vagina and esophageal eluates 1:2 (Table 
£1). Various amounts of tissue, however, were 
available for elution studies. The wet weights of 
materials available for elution were these: skin. 22 
gm; esophagus. -l gm; vagina, 7.5 gm; and trachea, 
l gm. {nterestingly, the elution procedure demon-
strated antibody in the trachea that was not 
detectable by direct immunofluorescence (Fig. 2 A 
and B). This indicates that the elution technique is 
more sensitive in detecting antibody than is direct 
i m m unoll uorescence. 
TABLE 11 
Titers of basement-membrane antrbod\ in bullou.~ 
pemphrgoid 
Prior to death (4 month~l 
Whole serum 
Blister 11uid 
Terminal 
\\'hole serum 
Skin eluate 
Trochea eluate 
Vagrna eluate 
Esophagus eluate 
Anll-l~tG Titer.-• 
1:512 
1: 512 
eg 
I : !32 
1 :a2 
I . •> 
l . •) 
• Anti lgM and {3, ,/(3 11 were negative. 
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FtG . 3: A: Absence at BMZ of trachea of antibody 
bound in vivo. (li'luorescein ·cOnJugated antihuman lgC, 
1:25 dilution; reduced (rom · 2.';()) H: Tra.:heal eluate 
applied to monkey esophagus showtng stnk1ng basement· 
membrane antibody. ( F'lunre~{'em-conjugated ant1human 
lg(:. 1: 125 diluuon: redu<'l'd lmm . 1001 
Complement-fixing ability. No eluted base-
ment-membrane antibody was capable of fixing 
complement. This finding correlates with the find-
ing of a lack of complement-fixing ability of the 
antibody in serum and blister fluid. The presence 
of C3 fixed to the skin 4 months prior to death 
could be explained partially by the alternate 
pathway of complement activation, because pro-
perdin and C3PA also were present (Fig. 4). 
Activation of an alternate pathway, however, could 
not explain all findings, because C4-one of the 
early components of the complement cascade 
-could be demonstrated on the basement-mem -
brane area of the skin in November 1971. C lq was 
not demonstrable. 
Complement components in blister fluid. As 
pre\ iously described [7J, a comparison of total 
complement and complement-component values 
of sera and blister fluids of serologically posith·e 
bullous pemphigoid cases reveals decreased blister 
fluid values and relatively normal or elevated 
serum values. Table Ill summflrizes studies ol 
hemolytic complement components, C3PA, and 
transferrin. No total complement activity was 
demonstrable in this patient's blister flutd; and 
values of the individual components of the comple-
ment sequence were all low (except C8 and C9J, 
and C4, C3, and C5 were too low to be measurable . 
In addition, C3PA was not detected. Transferrin, a 
• 
. ........ . - -' 
-~-~ - ~ --
Flr .. 4: Studie, of complement-fixmg Ability. tl<:r>ider-
mis [E] ; dermis [Dj) A: Depo~its of C:3 along BMZ on 
skm biop~y specimen taken 4 months prior w patient's 
death ; r:l was negati,·e at timt> of death. (Fluorescein-
conJugated (1, ,/{J ,, . l :!l dilution: redul·ed lrnm ~OOl 
H: (';l proocuvawr along BMZ on sk1n b1opsy l'penmen 
t.akt'n 4 months prior w patient's dt·<llh. 1 F'luurescein-
conjugAted ant1human lg(; ; reclucPd lrnm • IOU) C: De-
pnsit,.. of lgA alnng hasemPnL membrane nt skin I nwnth;, 
prior to patu.•nt 'l> death. I Fluuresl't'lll·l'unjugated anll-
lgA: redul·ed lrom · 2i;Ol 
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high-molecular-weight protem (90,000) that is not 
depleted during complement activation, was pres-
ent in blister fluid , and its value was comparable to 
the values of CS and C9. These studies, like those 
reported previously [i I. are suggestive of local 
activation of the complement cascade in the blister 
fluids of patients with bullous pemphigoid . 
Specificity study. The basement-membrane 
staining of the fluorescein-tagged pemphigoid anti-
body (patient's own serum 4 months prior to death, 
labeled with serum DEAE fraction 2) was not 
blocked by prior incubation with excess unlabeled 
blister fluid or eluates {Table lV). 
[t is probable that we a re dealing with t~o 
antibodies. Unfortunately, all attempts to conju-
gate either skin or trachea eluate with !luorescein 
were unsuccessful. 
TABLE Jll 
Total complement•. complement component.,•, C;l 
proactn·ator <C.1PAlt. and trrmsferrin1 m serum and 
bltsler fluid in bullous pemphlgotd 
Smarte 
Component 
Serum Bl~'tcr nuid 
TotalC 10.1 0 
Cl 4:1,960 10,200 
C4 26.640 0 
C2 282 55 
C:l 320 0 
C5 484 0 
C6 59:! 4[) 
C'i 660 127 
C8 1:!,190 5,6:15 
C9 6,066 2,692 
('3PA 16.7 0 
Transferrin 554 208 
• A::; CH •• u/10 ml{ nl total prntcin 
t As l'g/10 mg of lntnl prote111 
Rnuunf 
Bl"ll'r 
Flu tel l 
Serum.' t 
... 
23 
... 
20 
... 
... 
8 
19 
4:i 
4 I 
... 
38 
t Amount of total complement. individual romple-
ment component. (':lPA. or transferrin 10 blister tluid 
rom pared to serum 
TABLE I\' 
BlockiiiJ/ experrmenls 1n bullou., prmphr{!rnd 
------------- -~ --
FlUid tn<·uhoted 
Wll h ("c>phll~US 
Saline 
Blister tlutd 
Whole serum 
Skm eluate 
0Hrlrucl 
wah ~erum 
l "'''• frof.Pt~t :!. Result~ 
C't•njUf(Hit~ 
tunit•l 
:1 I t 
8 :l It 
9 3 I ~ 
·I :l I t 
5 :l I • 
:l :) 
1 :1 t\e~ 
T rachea eluate 
Serum fraction :1 nr 4 
Serum fracunn 2 ______ _L ____ J_ ____ ~-----
• One unit is equal to highest dilut um givmg pusittve 
staining 
Serum al Time of Death 
At the time of death, no circulating antibody 
could be detected when homologous human skin or 
esophagus was used as the substrate. When, how-
ever, the serum was applied to the patient'!> own 
skin or esophagus (after complete removal by acid 
elution of antibody fixed in vivo} ba!>ement-mem-
brane s taining ciearly appeared (Fig. 5). The 
increased sensitivity of the autologous substrate 
also permitted better visualization of the weak 
eluates and resulted in a higher end-dilution of 
serum antibody (titer, 1:2.096 in serum 4 months 
prior to death). This sensitivity also indicates that 
both the antigenic sites within the basement mem-
brane and the F ~b fragment of the antibody are left 
intact, even under the extreme acidity of the 
elution technique. 
J>IS(TS~I 0 'I 
A central questiOn that has not yet been satisfac-
torily answered is whether the pemphigoid anti-
body is directly responsible for production of lesi~ns. Sams and Gleich [11] transferred antibody 
to monkeys, and though they obtained considera-
ble in vivo binding of antibody to the BMZ of the 
skin, no lesions were produced. This was inter-
preted as evidence that the antibody itself does not 
cause lesions. However, they offered another expla-
nation: the antibody circulating in the serum may 
not be the sa me as the one bound to ski n and 
responsi ble for lesions. A clinical observation also 
supports this explanation: in bullous pemphigoid, 
the serum antibody titer does not correlate well 
Y.ith the disea!-.e activity. and this would be ex-
plained hy the presence of two antibodies-one 
fixed to the skin and causing tissue damage. the 
other ctrculating in the serum and being nonpatho-
genic. 
The present study was undertaken to verify this 
possibility . The conjugate pemphigoid serum was 
not blocked by prior treatment with eluates. This 
may indicate either that more than one pem-
phigoid antibody is present in the serum of this 
patient or that serum antibody might be different 
from the one fixed to the tissue or present locally 
within the blister fluid. 
The results of the blocking experiments should 
be interpreted with some reservations because the 
serum was obtained 4 months prior to death, 
whereas the different eluate~ were obtained at the 
time of death. During those 4 months, corticoste-
roid therapy was resumed. the disease became 
inactive, and the serum antibody titer decreased 
from 1:512 to almost zer(). The production of 
antibody may have been halted completely and 
certain types of antihod~ may have disappeared 
because of their short half-life. The elution of the 
skin might have yielded a completely different 
result if it had been performed 4 months previ-
ously, when the disease activity was at its peak . 
The perplexing finding of complement fixed to 
the tissue in the presence of an antibody that does 
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FlG. 5. Intubation studies of e:;ophagus. A: Pat tent ·s 
esophagus incubated in saline O\ ernight. Note hnear 
deposit of lgG in RMZ. !Fluorescein conjugated antihu 
man lgG, reduced trom • 2fl0) H: !-lunilar ~('(·tum ol pa 
tient 's esophai(Us mcubated 111 citrate bullered at pH 2.2 
overmght. Notl' that deposit ol (g(: has ht>en removed by 
actd-elutwn procedure. t Fluorescem t'tlllJUI(Oted anti 
C3PA : redut·ed trnm 2fl01 ('· Sum~ Jlrl'pllratton a~ in 
B, followed by mcubatton with skm eluate Agam. elut~d 
pemphtgl)ld-anohody reacted markedlv \\llh llutologuu' 
substrat~ t Fluore~cein-cnnJugated antihumlln lgG: 
reduced trnm • 2;>01 
not fix complement needs to be examined further. 
Perhaps the complement-fixing ability of the anti -
body was not demonstrated for technical reasons . 
Possibly the amount of complement-fixing anti-
body was too small to be detected by in vitro 
staining of complement, especiallv with respect to 
eluate of esophagus and vagina with very low titers 
of IgG. It is conceivable that under conditions of 
extreme acidity in the elution procedure, the Fe 
fragment of the antibody may be modified in such 
a way that the ability to fix complement is lost. 
However, elution procedure does not always yield 
pemphigotd antibody that cannot tix compte. 
ment 1121. 
A recent observation of Provost and Tomasi (3]. 
who implicated activatton of the alternate path-
way m addition to the classic pathway, seems to 
reconcile the finding of universal complement 
fixation in vivo in bullous pemphigoid (13, 14jand 
the noncomplement-fixing ability of some circulat-
ing basement-membrane antibodies. 
In our patient, the activation of the alternate 
pathway possibly could be explained by aggregates 
of lgA that were bound to the basement membrane 
of the skin 4 months prior to death. Alternatively, 
aggregates of lgG-in our patient probably lgG4 
-could be responsible for the activation of the 
complement bypass. 
The presence of C4 (an early complement com-
ponent) fixed in the tissue indicates that the 
alternate pathway is not the sole explanation and 
that the classic pathway is also involved. This is 
also suggested by the low blister-complement 
value of the earlier components. 
Our studies confirm the prrvious work on tissue 
affinity of the pemphigoid antibody. Beutner, 
Chorzelski, and Jordon /1.'3) tested the pemphigoid 
antibody against various organs in several species 
and found that it reacted essentially with most 
epithelial basement membranes. Interestingly, the 
antibody can perfuse multiple internal organs and 
become attached to their epithelial basement 
membranes yet still not cause lesions. This, how-
ever, is not surpnsing because the pemphigoid 
antibody often can be detected by direct immuno-
fluorescence in the clinically normal skin of pa-
tients w1th the disease. Similar studies need to be 
carried out in patients with more active disease. 
The elution on slides permitted two interesting 
observations: ( ll that the patient's own tissue 
might be the be!lt antigenic source and that there is 
some way of using the patient's own tissue, in spite 
of the presence of previously fixed antibody; and 
(2l that the elution procedure dissociates the 
antibody but still leave~ the basement-membrane 
antigenic site intact. Thus, when the eluate is 
reapplied, it occupies exactly the sa me site and 
shows exactly the same pattern. 
Finally, our study emphasizes that the antibody 
can be present yet undemonstrable by routine 
procedures, and, further, that a pemphigoid anti-
body could be eluted from a skin specimen which. 
at first, appeared to be negative for the presence of 
)'-globulin. 
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